- Home
- ASTI vs PTIX Comparison
ASTI vs PTIX Comparison
Compare ASTI & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- PTIX
- Stock Information
- Founded
- ASTI 2005
- PTIX 1994
- Country
- ASTI United States
- PTIX United States
- Employees
- ASTI N/A
- PTIX N/A
- Industry
- ASTI Semiconductors
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- PTIX Health Care
- Exchange
- ASTI Nasdaq
- PTIX Nasdaq
- Market Cap
- ASTI 2.9M
- PTIX 2.9M
- IPO Year
- ASTI N/A
- PTIX 2016
- Fundamental
- Price
- ASTI $2.14
- PTIX $3.42
- Analyst Decision
- ASTI
- PTIX
- Analyst Count
- ASTI 0
- PTIX 0
- Target Price
- ASTI N/A
- PTIX N/A
- AVG Volume (30 Days)
- ASTI 6.8M
- PTIX 196.0K
- Earning Date
- ASTI 08-05-2025
- PTIX 08-13-2025
- Dividend Yield
- ASTI N/A
- PTIX N/A
- EPS Growth
- ASTI N/A
- PTIX N/A
- EPS
- ASTI N/A
- PTIX N/A
- Revenue
- ASTI $51,917.00
- PTIX N/A
- Revenue This Year
- ASTI N/A
- PTIX N/A
- Revenue Next Year
- ASTI N/A
- PTIX N/A
- P/E Ratio
- ASTI N/A
- PTIX N/A
- Revenue Growth
- ASTI N/A
- PTIX N/A
- 52 Week Low
- ASTI $1.10
- PTIX $2.35
- 52 Week High
- ASTI $10.45
- PTIX $15.54
- Technical
- Relative Strength Index (RSI)
- ASTI 49.82
- PTIX 45.21
- Support Level
- ASTI $1.71
- PTIX $3.33
- Resistance Level
- ASTI $2.64
- PTIX $3.58
- Average True Range (ATR)
- ASTI 0.25
- PTIX 0.24
- MACD
- ASTI -0.05
- PTIX 0.00
- Stochastic Oscillator
- ASTI 20.17
- PTIX 18.42
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.